Shiff Benjamin, Blankstein Udi, Hussaen Jafar, Jarvi Keith, Grober Ethan, Lo Kirk, Lajkosz Katherine, Krakowsky Yonah
Section of Urology, Department of Surgery, University of Manitoba, Winnipeg, MB, Canada.
Division of Urology, Department of Surgery, University of Toronto, Toronto, ON, Canada.
Can Urol Assoc J. 2021 Dec;15(12):E652-E657. doi: 10.5489/cuaj.7185.
Despite increasing consumption rates in much of the world, the impact of cannabis use on various components of male sexual function remains poorly established. The purpose of this study was to further evaluate the relationship between cannabis use and reproductive and sexual function using a large patient cohort from a single academic andrology clinic.
This is a historical cohort study from a single academic center andrology clinic. Patients from 2008-2017 were included. Intake questionnaires provided baseline demographic information, as well as data regarding substance use and various sexual function parameters. Subjects were categorized as cannabis users or non-users. Cannabis users and non-users were compared using descriptive statistics and Chi-squared tests, and regression analyses were performed to test for association.
A total of 7809 males were included in the study; 993 (12.7%) were cannabis users and 6816 (87.3%) were non-users. Cannabis users had a higher mean Sexual Health Inventory for Men (SHIM) score (21.9±4.4 vs. 21.2±4.8, p<0.001) and mean serum total testosterone (13.4±12.0 nmol/L vs. 12.6±11.8 nmol/L, p=0.04) than non-users, although they also had a higher rate of positive Androgen Deficiency in the Aging Male (ADAM) scores (52% vs. 46%, p<0.001). Cannabis users also reported higher sexual frequency compared to non-users (8.8 events/month vs. 7.8 events/month, p<0.05). On multivariate analysis, cannabis use was not associated with SHIM score or serum testosterone concentration. Cannabis use was associated with positive ADAM scores.
Cannabis use was not associated with clinically significant deleterious effects on male sexual parameters in this cohort.
尽管世界上许多地区大麻的消费率不断上升,但大麻使用对男性性功能各个组成部分的影响仍未明确。本研究的目的是利用来自单一学术男科诊所的大量患者队列,进一步评估大麻使用与生殖和性功能之间的关系。
这是一项来自单一学术中心男科诊所的历史性队列研究。纳入了2008年至2017年的患者。入院调查问卷提供了基线人口统计学信息,以及关于物质使用和各种性功能参数的数据。受试者被分为大麻使用者或非使用者。使用描述性统计和卡方检验对大麻使用者和非使用者进行比较,并进行回归分析以检验关联性。
该研究共纳入7809名男性;993名(12.7%)为大麻使用者,6816名(87.3%)为非使用者。大麻使用者的男性性健康量表(SHIM)平均得分(21.9±4.4对21.2±4.8,p<0.001)和血清总睾酮平均水平(13.4±12.0 nmol/L对12.6±11.8 nmol/L,p=0.04)高于非使用者,尽管他们的老年男性雄激素缺乏(ADAM)阳性得分率也更高(52%对46%,p<0.001)。与非使用者相比,大麻使用者报告的性频率也更高(8.8次/月对7.8次/月,p<0.05)。多变量分析显示,大麻使用与SHIM得分或血清睾酮浓度无关。大麻使用与ADAM阳性得分有关。
在该队列中,大麻使用与对男性性参数的临床显著有害影响无关。